Literature DB >> 10433483

Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells.

K Fukuda1, Y Hibiya, M Mutoh, M Koshiji, S Akao, H Fujiwara.   

Abstract

The enzyme cyclooxygenase-2 (COX-2) is abundantly expressed in colon cancer cells and plays a key role in colon tumorigenesis. Compounds inhibiting COX-2 transcriptional activity have therefore potentially a chemopreventive property against colon tumor formation. An assay method for estimating COX-2 transcriptional activity in human colon cancer cells was established using a beta-galactosidase reporter gene system, and examination was made of various medicinal herbs and their ingredients for an inhibitory effect on COX-2 transcriptional activity. We found that berberine, an isoquinoline alkaloid present in plants of the genera Berberis and Coptis, effectively inhibits COX-2 transcriptional activity in colon cancer cells in a dose- and time-dependent manner at concentrations higher than 0.3 microM. The present findings may further explain the mechanism of anti-inflammatory and anti-tumor promoting effects of berberine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433483     DOI: 10.1016/s0378-8741(98)00162-7

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  40 in total

1.  Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.

Authors:  Ajaikumar B Kunnumakkara; Bokyung Sung; Jayaraj Ravindran; Parmeswaran Diagaradjane; Amit Deorukhkar; Sanjit Dey; Cemile Koca; Zhimin Tong; Juri G Gelovani; Sushovan Guha; Sunil Krishnan; Bharat B Aggarwal
Journal:  Int J Cancer       Date:  2011-11-09       Impact factor: 7.396

2.  Quantitative analysis of anti-inflammatory activity of orengedokuto: importance of combination of flavonoids in inhibition of PGE2 production in mouse macrophage-like cell line J774.1.

Authors:  Naohiro Oshima; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2012-06-23       Impact factor: 2.343

3.  Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway.

Authors:  Ji Hye Kim; Byoungduck Park; Subash C Gupta; Ramaswamy Kannappan; Bokyung Sung; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2011-12-15       Impact factor: 8.401

4.  Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E₂ and prostaglandin E₂ receptors.

Authors:  Tripti Singh; Mudit Vaid; Nandan Katiyar; Samriti Sharma; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2010-10-25       Impact factor: 4.944

5.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

6.  Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production.

Authors:  Naohiro Oshima; Tomofumi Shimizu; Yuji Narukawa; Noriyasu Hada; Fumiyuki Kiuchi
Journal:  J Nat Med       Date:  2018-04-18       Impact factor: 2.343

7.  Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer.

Authors:  Motilal Maiti; Gopinatha Suresh Kumar
Journal:  J Nucleic Acids       Date:  2009-12-15

8.  Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo.

Authors:  Yuchen Cai; Qing Xia; Rongzhen Luo; Peiyu Huang; Yueli Sun; Yanxia Shi; Wenqi Jiang
Journal:  J Nat Med       Date:  2013-04-21       Impact factor: 2.343

9.  Berberine inhibits the expression of TNFalpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARgamma pathway.

Authors:  F L Chen; Z H Yang; Y Liu; L X Li; W C Liang; X C Wang; W B Zhou; Y H Yang; Ren-Ming Hu
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

10.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.